脉冲染料激光、曲安奈德注射和外用卡替洛尔治疗 婴幼儿浅表性血管瘤的疗效分析.

Objective To explore the effectiveness and safety of pulsed dye laser, triamcinolone acetonide injection and external use of 2% carteolol in the treatment of superficial infantile hemangioma. Methods From April 2020 to June 2021, 90 infants (less than 6 months) with superficial hemangioma were randomly divided into pulsed dye laser group (laser group), triamcinolone acetonide injection group (injection group) and external use of carteolol group (external group), 30 infants in each group. The clinical efficacy at 3 and 6 months after treatment was observed. Results A total of 65 infants were contained in the final statistics, including 18 cases in the external group, 24 cases in the laser group and 23 cases in the injection group. At 6 months after treatment, there was no statistically significant difference in excellent and good rate among 3 groups (P>0.05). There was statistically significant difference in effective rate between the laser group and the external group (P<0.05). There was no statistically significant difference in thickness of lesions among 3 groups (P>0.05). There was statistically significant difference in thickness of lesions between 3 months after treatment and before treatment within the laser group and the injection group (P<0.05), While there was no statistically significant difference in the external group (P<0.05). Conclusion The pulsed dye laser, triamcinolone acetonide injection and external use of carteolol alone can obtain satisfactory efficacy in the treatment of superficial infantile hemangioma. The pulsed dye laser treatment hasrelatively certain advantages. [ABSTRACT FROM AUTHOR]